Found: 14
Select item for more details and to access through your institution.
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment.
- Published in:
- Scientific Reports, 2016, p. 34397, doi. 10.1038/srep34397
- By:
- Publication type:
- Article
Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.
- Published in:
- Scientific Reports, 2016, p. 27458, doi. 10.1038/srep27458
- By:
- Publication type:
- Article
A humanized mouse model for adeno-associated viral gene therapy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46017-0
- By:
- Publication type:
- Article
De-Regulation of JNK and JAK/STAT Signaling in <i>ESCRT-II</i> Mutant Tissues Cooperatively Contributes to Neoplastic Tumorigenesis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056021
- By:
- Publication type:
- Article
Notch Signaling Activates Yorkie Non-Cell Autonomously in Drosophila.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. e37615, doi. 10.1371/journal.pone.0037615
- By:
- Publication type:
- Article
Common and Distinct Genetic Properties of ESCRT-II Components in Drosophila.
- Published in:
- PLoS ONE, 2009, v. 4, n. 1, p. 1, doi. 10.1371/journal.pone.0004165
- By:
- Publication type:
- Article
Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 12, doi. 10.3390/cancers16010012
- By:
- Publication type:
- Article
Animal Modeling of Pediatric Liver Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 273, doi. 10.3390/cancers12020273
- By:
- Publication type:
- Article
Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21270, doi. 10.1002/cam4.6705
- By:
- Publication type:
- Article
Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.
- Published in:
- 2015
- By:
- Publication type:
- journal article
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82542-4
- By:
- Publication type:
- Article
Targeting LRH-1 in hepatoblastoma cell lines causes decreased proliferation.
- Published in:
- Oncology Reports, 2019, v. 41, n. 1, p. 143, doi. 10.3892/or.2018.6793
- By:
- Publication type:
- Article